Back to state act
Description
On 21 August 2020, the Norwegian Medicines Agency introduced an export notification on immunoglobulins as so far as it related to immunoglobulins in the following doses: Hizentra 200 mg/ml, 20 ml hgl,...
Sign in to see full description
Intervention Details
Intervention Type
Export licensing requirement
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
21 Aug 2020
Revocation date
03 Mar 2021
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 4 products
Threads
See all
This intervention is not part of any Thread yet.